Ledger.Open graph →
SEC Form D · filed February 22, 2021

EpiVax Therapeutics, Inc

Offering
$3.0M
Sold
$425K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PROVIDENCE, RI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Clifford Grimm · Providence, RIExecWilliam Martin · Providence, RIExec · DirectorRichard Lipkin · Providence, RIDirectorAnne De Groot · Providence, RIExec · DirectorDaniel Adams · Providence, RIDirectorNicholas W. Hauser · NEW YORK, NYDirectorRichard L. Chilton · Stamford, CTExec · DirectorPolina W. Kushelev · NEW YORK, NYDirectorChilton Investment Services, LLC · Stamford, CTExec · DirectorStephen P. Schuler · Chicago, ILExecAndrew Clark · Duxbury, MAExec · DirectorSusan E. Lattman · Basking Ridge, NJExec · DirectorAlun Williams · NEW YORK, NYExecJoshua N. Baer · Beaverton, ORDirectorAileen Lee · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗